Oystein Rekdal
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Immunobiological mechanisms of action of oncolytic peptides.
Journal: Journal for immunotherapy of cancer
Published: January 20, 2026
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcoma.
Journal: Oncoimmunology
Published: December 21, 2023
LTX-315 triggers anticancer immunity by inducing MyD88-dependent maturation of dendritic cells.
Journal: Frontiers in immunology
Published: November 03, 2023
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells.
Journal: Oncoimmunology
Published: August 19, 2021
Oncolytic peptides DTT-205 and DTT-304 induce complete regression and protective immune response in experimental murine colorectal cancer.
Journal: Scientific reports
Published: November 27, 2020
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides.
Journal: Trends in cancer
Published: November 05, 2020
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 11, 2020
Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms.
Journal: JCO global oncology
Published: September 08, 2020
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Journal: Journal for immunotherapy of cancer
Published: January 13, 2020
LTX-315 sequentially promotes lymphocyte-independent and lymphocyte-dependent antitumor effects.
Journal: Cell stress
Published: December 05, 2019
Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: a case report.
Journal: Journal of medical case reports
Published: March 22, 2019
Tumor lysis with LTX-401 creates anticancer immunity.
Journal: Oncoimmunology
Published: January 22, 2019
Last Updated: 09/26/2026